Hepatic veno-occlusive disease (HVOD) is a rare pathological condition characterized by occlusion of the hepatic veins and/or their major branches, resulting in impaired venous outflow from the liver. This disease is often accompanied by secondary acute or chronic liver damage, including portal hypertension, ascites, liver failure and possible acute hepatic encephalopathy. HVOD can occur as an isolated disease or be associated with various conditions, such as myeloproliferative diseases, autoimmune disorders and infections, making its diagnosis and treatment challenging.
History of the disease and interesting historical facts
Understanding hepatic veno-occlusive disease has come a long way. The first mentions of such conditions date back to the mid-20th century, when scientists began to note cases of liver failure associated with venous occlusion. In 1935, French pathologist René Fonstein described the clinical picture associated with hepatic vein thrombosis, coining the term “veno-occlusive disease.” Subsequently, in the 1970s, extensive research into the mechanism and etiology of the disease arose, which contributed to improved clinical approaches to its diagnosis and treatment. Interestingly, in some cases, PVOD was associated with certain genetic predispositions and environmental influences, which provided additional impetus for research in this area.
Epidemiology
The epidemiology of hepatic veno-occlusive disease shows that it is a rare disease occurring in both developing and developed countries. According to various studies, the incidence of PVOD varies from 1 to 2 cases per 100,000 population. However, in certain population groups, such as patients with myeloproliferative diseases, the incidence is significantly higher and can be up to 20%. In addition, statistics show that PVOD is more common in men aged 30 to 50 years, while in women the disease occurs much less frequently.
Genetic predisposition to this disease
Genetic factors play an important role in the development of hepatic veno-occlusive disease. Studies have shown that approximately 50% cases of PVOD may be associated with inherited mutations in genes responsible for hemostasis, including genes encoding prothrombin, factor V, and other coagulation factors. Specific mutations in the F2 (prothrombin) and F5 (factor V Leiden) genes increase the risk of thrombosis, which can lead to occlusion of the liver veins. It is also important to note that a combination of genetic predisposition and environmental factors can significantly increase the likelihood of developing this pathology.
Risk factors for the development of this disease
Among the risk factors that contribute to the development of hepatic veno-occlusive disease, both physical and chemical agents are distinguished:
- Acute infectious diseases such as viral hepatitis can weaken the hepatic vasculature.
- Excessive alcohol consumption leads to damage to liver tissue and can contribute to the development of thrombosis.
- Hemostasis disorders such as thrombophilia are an important risk factor.
- Pregnancy and the perinatal period may be associated with changes in coagulation and an increased risk of thrombosis.
- The development of blood diseases, such as myeloproliferative syndromes, greatly increases the risk of developing PVOD.
Diagnosis of this disease
Diagnosis of hepatic veno-occlusive disease is carried out taking into account the clinical picture and a number of laboratory and instrumental studies. The main symptoms include:
- Pain in the right hypochondrium associated with an enlarged liver.
- Ascites, which may be a result of portal hypertension.
- Jaundice caused by a disturbance in bilirubin metabolism.
- General symptoms such as fatigue, weakness and loss of appetite.
Laboratory tests include a coagulogram, blood chemistry, and bilirubin levels. Radiological methods — ultrasound, CT, and MRI — allow visualization of changes in the liver structure and assessment of the vascular system, identifying signs of thrombosis. Other studies may include liver biopsy for histological analysis. Differential diagnosis is performed with conditions such as liver cirrhosis, acute and chronic hepatitis, and other vascular liver pathologies.
Treatment
Treatment of hepatic veno-occlusive disease includes general, pharmacological, and surgical approaches. Initial measures are aimed at correcting the coagulation status and treating concomitant diseases. Pharmacological treatment involves the use of anticoagulants, such as heparin and warfarin, to prevent thrombus formation. In severe cases, surgical intervention is possible, including bypass to reduce portal pressure. Intravenous infusions aimed at correcting metabolic disorders and maintaining liver function make a significant contribution to therapy.
List of medications used to treat this disease
- Heparin - to prevent thrombus formation.
- Warfarin is an oral anticoagulant for long-term therapy.
- Sandostatin - in the presence of ascites and portal hypertension.
- Hepatoprotectors - to improve liver function and protect cells.
- Corticosteroids - in case of involvement of autoimmune mechanisms.
Disease monitoring
Monitoring of patients with hepatic veno-occlusive disease includes regular examinations and monitoring of changes in health status. The prognosis of the disease varies depending on the degree of liver involvement and the presence of concomitant diseases. Complications such as liver failure and acute encephalopathy can significantly worsen the quality of life. Pathological changes in liver tissue can progress, which requires constant monitoring and assessment of the functional status of the liver.
Age-related features of the disease
Hepatic veno-occlusive disease may manifest itself differently depending on the patient's age. In children, the disease may be associated with congenital hemostasis defects and, as a rule, develops more acutely. In adults, chronic processes are more common, which leads to the gradual development of liver failure. Elderly patients often have more concomitant diseases, which complicates diagnosis and prognosis.
Questions and Answers
- What are the main symptoms of PVOD? The main symptoms include pain in the right hypochondrium, ascites, jaundice, loss of appetite and weakness.
- How is hepatic veno-occlusive disease diagnosed? Diagnosis is made based on clinical symptoms, laboratory tests and imaging techniques such as ultrasound, CT or MRI.
- How is PVOB treated? Treatment includes anticoagulant therapy, supportive care and, if necessary, surgery.
- What are the risk factors for developing PVOD? Risk factors include blood diseases, alcohol dependence, viral hepatitis and pregnancy.
- What is the prognosis for patients with PVOD? The prognosis depends on the severity of the disease and the presence of complications, but timely diagnosis and treatment can improve the outcome.
Advice from Dr. Oleg Korzhikov
Dr. Oleg Korzhikov recommends the following for the management of hepatic veno-occlusive disease:
— *Have regular medical checkups and monitor your liver health.*
— *Be sure to report any new symptoms or changes in your health to your doctor.*
— *Eat a diet rich in vitamins and minerals to support liver function.*
— *Avoid alcohol and toxic substances that can worsen liver conditions.*
— *Monitor your coagulation levels and take prescribed medications strictly as directed by your doctor.*
By following these recommendations, patients can significantly improve their quality of life and reduce the risk of complications associated with hepatic veno-occlusive disease.
